US 11458126
DHODH inhibitor for use in treating hematologic cancers
granted A61KA61K31/437A61K31/53
Quick answer
US patent 11458126 (DHODH inhibitor for use in treating hematologic cancers) held by PTC THERAPEUTICS, INC. expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/437, A61K31/53, A61K9/0053, A61P